• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴侣蛋白对淀粉样蛋白的管理:蛋白质寡聚体双重功能背后的奥秘。

Amyloid management by chaperones: The mystery underlying protein oligomers' dual functions.

作者信息

Arghavani Payam, Pirhaghi Mitra, Moosavi-Movahedi Faezeh, Mamashli Fatemeh, Hosseini Elnaz, Moosavi-Movahedi Ali Akbar

机构信息

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, 1417466191, Iran.

出版信息

Curr Res Struct Biol. 2022 Dec 7;4:356-364. doi: 10.1016/j.crstbi.2022.11.002. eCollection 2022.

DOI:10.1016/j.crstbi.2022.11.002
PMID:36523328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9747510/
Abstract

Protein oligomerization has two notable aspects: it is crucial for the performing cellular and molecular processes accurately, and it produces amyloid fibril precursors. Although a clear explanation for amyloidosis as a whole is lacking, most studies have emphasized the importance of protein misfolding followed by formation of cytotoxic oligomer structures, which are responsible for disorders as diverse as neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and metabolic disorders, such as type 2 diabetes. Constant surveillance by oligomeric protein structures known as molecular chaperones enables cells to overcome the challenge of misfolded proteins and their harmful assemblies. These molecular chaperones encounter proteins in cells, and benefit cell survival as long as they perform correctly. Thus, this review highlights the roles of structural aspects of chaperone protein oligomers in determining cell fate-either succumbing to amyloid oligomers or survival-as well as experimental approaches used to investigate these entities.

摘要

蛋白质寡聚化有两个显著方面

它对于准确执行细胞和分子过程至关重要,并且会产生淀粉样纤维前体。尽管目前尚缺乏对整个淀粉样变性的清晰解释,但大多数研究都强调了蛋白质错误折叠继而形成细胞毒性寡聚体结构的重要性,这些结构与多种疾病有关,如神经退行性疾病(如阿尔茨海默病和帕金森病)以及代谢紊乱(如2型糖尿病)。被称为分子伴侣的寡聚蛋白质结构持续进行监测,使细胞能够克服错误折叠蛋白质及其有害聚集体带来的挑战。这些分子伴侣在细胞中与蛋白质相遇,只要它们正常发挥作用,就能促进细胞存活。因此,本综述强调了伴侣蛋白寡聚体的结构方面在决定细胞命运(要么屈服于淀粉样寡聚体,要么存活)中的作用,以及用于研究这些实体的实验方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/25476fee79de/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/9831ec227d36/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/7fa29ad5da33/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/058514b41cb4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/7c672eb2e7ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/b21355342f01/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/25476fee79de/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/9831ec227d36/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/7fa29ad5da33/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/058514b41cb4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/7c672eb2e7ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/b21355342f01/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58de/9747510/25476fee79de/gr5.jpg

相似文献

1
Amyloid management by chaperones: The mystery underlying protein oligomers' dual functions.伴侣蛋白对淀粉样蛋白的管理:蛋白质寡聚体双重功能背后的奥秘。
Curr Res Struct Biol. 2022 Dec 7;4:356-364. doi: 10.1016/j.crstbi.2022.11.002. eCollection 2022.
2
Amyloid Disassembly: What Can We Learn from Chaperones?淀粉样蛋白解聚:我们能从伴侣蛋白中学到什么?
Biomedicines. 2022 Dec 17;10(12):3276. doi: 10.3390/biomedicines10123276.
3
Structural, morphological, and functional diversity of amyloid oligomers.淀粉样寡聚体的结构、形态和功能多样性。
FEBS Lett. 2015 Sep 14;589(19 Pt A):2640-8. doi: 10.1016/j.febslet.2015.07.013. Epub 2015 Jul 17.
4
Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.淀粉样寡聚物的结构及其毒性机制:利用新型治疗方法靶向淀粉样寡聚物。
Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.
5
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.错误折叠的蛋白质寡聚物:形成机制、细胞毒性作用以及针对蛋白质错误折叠疾病的药理学方法。
Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2.
6
Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity.伴侣蛋白作为蛋白质错误折叠寡聚体毒性的抑制因子。
Front Mol Neurosci. 2017 Apr 5;10:98. doi: 10.3389/fnmol.2017.00098. eCollection 2017.
7
Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.蛋白质稳态和 ATP 非依赖型分子伴侣对细胞内外蛋白质聚集的调控:晶状体α-晶体蛋白和乳清蛋白。
Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14.
8
Identification of on- and off-pathway oligomers in amyloid fibril formation.淀粉样纤维形成过程中“on-pathway”和“off-pathway”寡聚体的鉴定。
Chem Sci. 2020 Jun 8;11(24):6236-6247. doi: 10.1039/c9sc06501f. eCollection 2020 Jun 28.
9
Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.蛋白质寡聚化在阿尔茨海默病和帕金森病发病机制中的关键作用。
FEBS J. 2018 Oct;285(19):3631-3644. doi: 10.1111/febs.14587. Epub 2018 Aug 21.
10
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.蛋白质变性与聚集:细胞对变性及聚集蛋白的反应
Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030.

引用本文的文献

1
Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's.神经退行性变中的汇聚性病理:阿尔茨海默病和帕金森病中α-突触核蛋白与 Tau 蛋白之间的机制相互作用
Neurol Sci. 2025 Aug 26. doi: 10.1007/s10072-025-08421-2.
2
Photochemically synthesized gold nanoparticles conjugated with Boswellic acid inhibit alpha synuclein aggregation and delay fibrillation kinetics.光化学合成的与乳香酸共轭的金纳米颗粒可抑制α-突触核蛋白聚集并延缓纤维化动力学。
Sci Rep. 2025 Jul 17;15(1):25886. doi: 10.1038/s41598-025-11107-6.
3
Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness.

本文引用的文献

1
Protein chain collapse modulation and folding stimulation by GroEL-ES.GroEL-ES对蛋白质链折叠的调控及折叠促进作用
Sci Adv. 2022 Mar 4;8(9):eabl6293. doi: 10.1126/sciadv.abl6293.
2
Inhibiting mTTR Aggregation/Fibrillation by a Chaperone-like Hydrophobic Amino Acid-Conjugated SPION.通过一种具有伴侣样疏水性氨基酸的 SPION 抑制 mTTR 聚集/纤维形成。
J Phys Chem B. 2022 Mar 3;126(8):1640-1654. doi: 10.1021/acs.jpcb.1c08796. Epub 2022 Jan 28.
3
Unzipping the Secrets of Amyloid Disassembly by the Human Disaggregase.人解聚酶解析淀粉样蛋白组装体的奥秘
伴侣蛋白作为治疗蛋白质聚集疾病的潜在药理学靶点
Curr Protein Pept Sci. 2025 Jan 27. doi: 10.2174/0113892037338028241230092414.
4
The duality of amyloid-β: its role in normal and Alzheimer's disease states.淀粉样蛋白-β的双重性:在正常和阿尔茨海默病状态中的作用。
Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1.
Cells. 2021 Oct 14;10(10):2745. doi: 10.3390/cells10102745.
4
Redefining Molecular Chaperones as Chaotropes.将分子伴侣重新定义为促溶剂。
Front Mol Biosci. 2021 Jun 14;8:683132. doi: 10.3389/fmolb.2021.683132. eCollection 2021.
5
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.淀粉样寡聚体:阿尔茨海默病、帕金森病、2 型糖尿病和肌萎缩侧索硬化症的联合实验/计算研究视角。
Chem Rev. 2021 Feb 24;121(4):2545-2647. doi: 10.1021/acs.chemrev.0c01122. Epub 2021 Feb 5.
6
Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes.胰岛淀粉样多肽的蛋白稳态:II 型糖尿病风险因素和保护策略的分子视角。
Chem Rev. 2021 Feb 10;121(3):1845-1893. doi: 10.1021/acs.chemrev.0c00981. Epub 2021 Jan 11.
7
Tau Oligomers Neurotoxicity.tau蛋白寡聚体神经毒性
Life (Basel). 2021 Jan 6;11(1):28. doi: 10.3390/life11010028.
8
Alternative systems for misfolded protein clearance: life beyond the proteasome.错误折叠蛋白清除的替代系统:蛋白酶体之外的生命。
FEBS J. 2021 Aug;288(15):4464-4487. doi: 10.1111/febs.15617. Epub 2020 Nov 20.
9
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases.分子伴侣:神经退行性疾病中的双刃剑
Front Aging Neurosci. 2020 Oct 6;12:581374. doi: 10.3389/fnagi.2020.581374. eCollection 2020.
10
Identification of on- and off-pathway oligomers in amyloid fibril formation.淀粉样纤维形成过程中“on-pathway”和“off-pathway”寡聚体的鉴定。
Chem Sci. 2020 Jun 8;11(24):6236-6247. doi: 10.1039/c9sc06501f. eCollection 2020 Jun 28.